Lithium in Depression

References

• Amdisen A. Monitoring of lithium treatment through determination of lithium concentration. Danish Medical Bulletin 1975; 22: 277–91
   PubMed Web of Science ®Google Scholar
• Angst J. Clinical indications for a prophylactic treatment of depression. Advances in Biological Psychiatry 1981; 7: 218–29
   Google Scholar
• Angst J., Weis P., Grof P., et al. Lithium prophylaxis in recurrent affective disorders. British Journal of Psychiatry 1970; 116: 604–14
   PubMed Web of Science ®Google Scholar
• Baastrup P. The use of lithium in manic depressive psychosis. Comprehensive Psychiatry 1964; 5: 396–408
   PubMed Web of Science ®Google Scholar
• Baastrup P., Schou M. Lithium as a prophylactic agent — its effects against recurrent depressions and manic depressive psychosis. Archives of General Psychiatry 1967; 16: 162–72
   PubMed Web of Science ®Google Scholar
• Baron M., Gershon E. S., Rudy V., et al. Lithium carbonate response in depression: prediction by unipolar/bipolar illness, average evoked response, catechol-O-methyl transferase, and family history. Archives of General Psychiatry 1975; 32: 1107–11
   PubMed Web of Science ®Google Scholar
• Byerley W., Risch C. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment. Journal of Clinical Psychopharmacology 1985; 5: 191–206
   PubMed Web of Science ®Google Scholar
• Coppen A., Abou-Saleh M. Lithium in the prophylaxis of unipolar depression: a review. Journal of the Royal Society of Medicine 1983; 76: 297–301
   PubMed Web of Science ®Google Scholar
• Coppen A., Abou-Saleh M., Milln P., et al. Decreasing lithium dosage reduced morbidity and side effects during prophylaxis. Journal of Affective Disorders 1983; 5: 353–62
   PubMed Web of Science ®Google Scholar
• Davis J. M. Maintenance therapy in psychiatry: II. Affective Disorders. American Journal of Psychiatry 1976; 133: 1–11
   PubMed Web of Science ®Google Scholar
• De Montigny C., Grunberg F., Mayer A., Deschenes J.-P. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. British Journal of Psychiatry 1981; 138: 252–6
   PubMed Web of Science ®Google Scholar
• De Montigny C., Cournoyer G., Morissette R., et al. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Archives of General Psychiatry 1983; 40: 1327–34
   PubMed Web of Science ®Google Scholar
• De Montigny G., Elie R., Caille G. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study. American Journal of Psychiatry 1985; 142: 220–3
   PubMed Web of Science ®Google Scholar
• Elphick M. An open clinical trial of carbamazepine in treatment-resistant bipolar and schizo-affective psychotics. British Journal of Psychiatry 1985; 147: 198–200
   PubMed Web of Science ®Google Scholar
• Fieve R., Platman S. R., Plutchik R. R. The use of lithium in affective disorders: I. Acute endogenous depression. American Journal of Psychiatry 1968; 125: 487–98
   PubMed Web of Science ®Google Scholar
• Fieve R., Dunner D., Kumbarachi T., Stallone F. Lithium carbonate in affective disorders. Archives of General Psychiatry 1975; 32: 1541–4
   PubMed Web of Science ®Google Scholar
• Glen A., Johnson L., Shepherd M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomised double blind, controlled trial. Psychological Medicine 1984; 14: 37–50
   PubMed Web of Science ®Google Scholar
• Goodnick P., Fieve R. Plasma lithium level and interepisode functioning in bipolar disorder. American Journal of Psychiatry 1985; 142: 761–2
   PubMed Web of Science ®Google Scholar
• Goodwin F. K., Murphy D. L., Dunner D. L., Bunney W.Jr. Lithium response in unipolar versus bipolar depression. American Journal of Psychiatry 1972; 129: 44–7
   PubMed Web of Science ®Google Scholar
• Hartigan G. The use of lithium salts in affective disorders. British Journal of Psychiatry 1963; 109: 810–14
   PubMed Web of Science ®Google Scholar
• Heninger G. R., Charney D. S., Sternberg D. E. Lithium carbonate augmentation of antidepressant treatment. Archives of General Psychiatry 1983; 40: 1335–42
   PubMed Web of Science ®Google Scholar
• Himmelhoch J., Detre T., Kupeer D., et al. Treatment of previously intractable depressions with tranylcypromine and lithium. Journal of Nervous and Mental Disease 1972; 155: 215–20
   Web of Science ®Google Scholar
• Hullin R. P. Minimum effective plasma lithium levels for long-term preventive treatment of recurrent affective disorders. Lithium Controversies and Unresolved Issues., T. Cooper, S. Gershon, N. Kline, M. Schou, 1979, International Congress Series 478
   Google Scholar
• Jerram T., McDonald R. Plasma lithium control with particular reference to minimum effective levels. Lithium in Medical Practice, F. Johnson, S. Johnson. MTP Press, Lancaster 1978
   Google Scholar
• Johnson G. Antidepressant effect of lithium. Comprehensive Psychiatry 1974; 15: 43–7
   PubMed Web of Science ®Google Scholar
• Johnson G. Lithium. Medical Journal of Australia 1984; 141: 595–601
   PubMed Web of Science ®Google Scholar
• Johnson G., Hunt G., Lewis J., St George G. Phamacokinetics of standard (Lithicarb) and sustained release (Priadel) lithium carbonate preparations in patients. Australian and New Zealand Journal of Psychiatry 1982; 16: 64–8
   PubMed Web of Science ®Google Scholar
• Johnson G., Hunt G., Duggin G., et al. Renal function and lithium treatment: initial and follow up tests in manic depressive patients. Journal of Affective Disorders 1984; 6: 249–63
   PubMed Web of Science ®Google Scholar
• JøRgensen F., Larsen S., Spanager B., et al. Kidney function and quantitative histological changes in patients on long-term lithium therapy. Acta Psychiatrica Scandinavica 1984; 70: 455–62
   PubMed Web of Science ®Google Scholar
• Joyce P. R., Huyland H. R., Jones A. V. Rapid response to lithium in treatment resistant depression. British Journal of Psychiatry 1983; 142: 204–5
   PubMed Web of Science ®Google Scholar
• Kane J., Quitkin F., Rifkin A., et al. Lithium carbonate and imipramine in prophylaxis of unipolar and bipolar II illness. Archives of General Psychiatry 1982; 39: 1065–9
   PubMed Web of Science ®Google Scholar
• Kishimoto A., Ogura C., Hazama H., Inoue K. Long term prophylactic effects of carbamazepine in affective disorder. British Journal of Psychiatry 1983; 143: 327–32
   PubMed Web of Science ®Google Scholar
• Kupfer D., Detre T. Tricyclic and monoamine oxidase inhibitor antidepressants clinical use. Handbook of Psychopharmacology. Vol. 14, Affective Disorders — Drug Actions in Animals and Man, L. Iversen, S. Iversen, S. Snyder. Plenum Press, New York 1978
   Google Scholar
• Lingjaerde O., Edlund A., Gormsen C., et al. The effect of lithium carbonate in combination with tricyclic antidepressants and endogenous depression. A double blind multi centre trial. Acta Psychiatrica Scandinavica 1974; 50: 233–42
   PubMed Web of Science ®Google Scholar
• Løkkegaard J., Andersen N., Henriksen E., et al. Renal function in 153 manic-depressive patients treated with lithium for more than five years. Acta Psychiatrica Scandinavica 1985; 71: 347–55
   PubMed Web of Science ®Google Scholar
• Mendels J. Lithium in the treatment of depression. American Journal of Psychiatry 1976; 133: 373–8
   PubMed Web of Science ®Google Scholar
• Mendels J., Secunda S. K., Dyson W. L. A controlled study of the antidepressant effects of lithium carbonate. Archives of General psychiatry 1972; 26: 154–7
   PubMed Web of Science ®Google Scholar
• Mendels J., Ramsey A., Dyson W. L., Frazer A. Lithium as an antidepressant. Archives of General Psychiatry 1979; 36: 845–6
   PubMed Web of Science ®Google Scholar
• Nelson J. C., Byck R. Rapid response to lithium in phenelzine non responders. British Journal of Psychiatry 1982; 141: 85–6
   PubMed Web of Science ®Google Scholar
• Noack C., Trautner E. The lithium treatment of maniacal psychosis. Medical Journal of Australia 1951; 2: 219–22
   PubMedGoogle Scholar
• Nolen W. A. Carbamazepine, a possible adjunctor alternative to lithium in bipolar disorder. Psychiatrica Scandinavica 1983; 67: 218–28
   PubMed Web of Science ®Google Scholar
• Noyes R., Jr, Dempsey G. M., Blum A., Cavanaugh G. L. Lithium treatment of depression. Comprehensive Psychiatry 1974; 15: 187–198
   PubMed Web of Science ®Google Scholar
• Okuma T., Kishimoto A., Inoue K. Antimanic and prophylatic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatrica Neurologica (Japan) 1973; 27: 283–7
   PubMedGoogle Scholar
• Okuma T., Inanaga K., Otsuki S., et al. A preliminary double-blind study on the efficacy of carbamazepine in the prophylaxis of manic depressive illness. Psychopharmacology 1981; 73: 95–6
   PubMed Web of Science ®Google Scholar
• Plenge P., Mellerup E., Bolwig T., et al. Lithium treatment: does the kidney prefer one daily dose instead of two?. Acta Psychiatrica Scandinavica 1982; 66: 121–8
   PubMed Web of Science ®Google Scholar
• Post R., Uhde T. Carbamazepine in psychiatric disorders. Psychopharmacology Bulletin 1985; 21: 10–16
   PubMedGoogle Scholar
• Price L. H., Charney D. S., Heninger G. R. Efficacy of lithium — trancylcypromine treatment in refractory depression. American Journal of Psychiatry 1985; 142: 619–23
   PubMed Web of Science ®Google Scholar
• Prien R., Caffey E. Relationship between dosage and response to lithium prophylaxis in recurrent depression. American Journal of Psychiatry 1976; 133: 567–70
   PubMed Web of Science ®Google Scholar
• Prien R., Klett C., Caffey E. Lithium prophylaxis in recurrent affective illness. American Journal of Psychiatry 1974; 131: 198–203
   PubMed Web of Science ®Google Scholar
• Prien R., Kupfer D., Mansky P., et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Archives of General Psychiatry 1984; 41: 1096–104
   PubMed Web of Science ®Google Scholar
• Schou M. Lithium in psychiatric therapy and prohylaxis. Journal of Psychiatric Research 1968; 6: 67–95
   PubMed Web of Science ®Google Scholar
• Schou M. Lithium as a prophylactic agent in unipolar affective illness. Archives of General Psychiatry 1979; 36: 849–51
   PubMed Web of Science ®Google Scholar
• Schou M., Juel-Nielsen N., Stromgren E., Voldby H. The treatment of manic psychosis by the administration of lithium salts. Journal of Neurology, Neurosurgery and Psychiatry 1954; 17: 250–60
   PubMed Web of Science ®Google Scholar
• Schou M., Amdisen A., Thomsen K., et al. Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology 1982; 77: 387–90
   PubMed Web of Science ®Google Scholar
• Shukla S., Godwin C., Long L., Miller M. Lithium-carbamazepine neurotoxicity and risk factors. American Journal of Psychiatry 1984; 141: 1604–6
   PubMed Web of Science ®Google Scholar
• Shukla S., Cook B., Miller M. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness. Journal of Affective Disorders 1985; 9: 219–22
   PubMed Web of Science ®Google Scholar
• Stokes P. E., Shamoian C. A., Stoll P. M., Patton M. J. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971; 1: 1319–25
   PubMed Web of Science ®Google Scholar
• Takezaki H., Hanaoka H. The use of carbamazepine in control of manic depressive psychosis and other manic depressive states. Seishinigaku 1971; 13: 173–138, (in Japanese)
   Google Scholar
• Waters B., Lapierre Y., Gagnon A., et al. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biological Psychiatry 1982; 17: 1323–9
   PubMed Web of Science ®Google Scholar
• Worrall E. P., Moody J. P., Peet M., et al. Controlled studies of the acute antidepressant effects of lithium. British Journal of Psychiatry 1979; 135: 255–62
   PubMed Web of Science ®Google Scholar
• Yang Y. Prophylactic efficacy of lithium and its effective plasma levels in Chinese bipolar patients. Acta Psychiatrica Scandinavica 1985; 71: 171–5
   PubMed Web of Science ®Google Scholar
• Zall H. Lithium carbonate and isocarboxazid. An effective drug approach in severe depressions. American Journal of Pshychiatry 1971; 127: 1400–3
   PubMed Web of Science ®Google Scholar